D. E. Shaw & Co., Inc. Alaunos Therapeutics, Inc. Transaction History

D. E. Shaw & Co., Inc.

$98.6 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.41 - $1.24 $377,264 - $1.14 Million	-920,158 Reduced 83.14%	186,601 $231,000
Q1 2022 May 16, 2022	BUY	$0.62 - $1.17 $90,691 - $171,142	146,276 Added 15.23%	1,106,759 $722,000
Q4 2021 Feb 14, 2022	BUY	$1.09 - $1.89 $207,411 - $359,640	190,286 Added 24.71%	960,483 $1.05 Million
Q3 2021 Nov 15, 2021	BUY	$1.44 - $2.73 $116,038 - $219,988	80,582 Added 11.69%	770,197 $1.4 Million
Q2 2021 Aug 16, 2021	SELL	$2.63 - $3.67 $769,574 - $1.07 Million	-292,614 Reduced 29.79%	689,615 $1.82 Million
Q1 2021 May 17, 2021	BUY	$2.82 - $5.6 $1.52 Million - $3.02 Million	539,992 Added 122.1%	982,229 $3.54 Million
Q4 2020 Feb 16, 2021	BUY	$2.09 - $3.09 $377,819 - $558,594	180,775 Added 69.14%	442,237 $1.11 Million
Q3 2020 Nov 16, 2020	SELL	$2.39 - $3.43 $375,526 - $538,935	-157,124 Reduced 37.54%	261,462 $659,000
Q2 2020 Aug 14, 2020	BUY	$2.2 - $3.71 $920,889 - $1.55 Million	418,586 New	418,586 $1.37 Million
Q1 2020 May 15, 2020	SELL	$1.9 - $4.98 $257,104 - $673,883	-135,318 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.95 - $5.35 $326,582 - $442,332	82,679 Added 157.07%	135,318 $639,000
Q3 2019 Nov 14, 2019	SELL	$4.13 - $6.94 $1 Million - $1.69 Million	-243,245 Reduced 82.21%	52,639 $225,000
Q2 2019 Aug 14, 2019	BUY	$3.98 - $6.2 $1.18 Million - $1.83 Million	295,884 New	295,884 $1.73 Million
Q1 2019 May 15, 2019	SELL	$2.0 - $4.4 $1.06 Million - $2.33 Million	-530,108 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$1.61 - $3.62 $242,723 - $545,751	150,760 Added 39.74%	530,108 $991,000
Q3 2018 Nov 14, 2018	BUY	$2.26 - $3.27 $591,177 - $855,376	261,583 Added 222.12%	379,348 $1.21 Million
Q2 2018 Aug 14, 2018	BUY	$3.02 - $4.94 $98,464 - $161,063	32,604 Added 38.29%	117,765 $356,000
Q1 2018 May 15, 2018	BUY	$3.46 - $5.14 $74,241 - $110,288	21,457 Added 33.68%	85,161 $334,000
Q4 2017 Feb 14, 2018	SELL	$4.0 - $6.54 $318,744 - $521,146	-79,686 Reduced 55.57%	63,704 $264,000
Q3 2017 Nov 14, 2017	BUY	$4.99 - $6.57 $715,516 - $942,072	143,390	143,390 $880,000

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $443M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account